Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:
Noted for its ‘outstanding knowledge of pharma patent litigation’, the IP department at Clifford Chance remains a top choice in the Spanish market for multinational companies operating in the consumer goods, retail, media, life sciences and telecoms sectors, among others. In addition to its strong capabilities in patent litigation at the domestic and European levels, the group is also proficient in licencing issues, enforcement actions, and administrative proceedings. Leading the team is the ’highly respected, pragmatic, and creative’ Miquel Montañá, who stands out for his aptitude in multijurisdictional patent litigation and infringement matters. Josep Montefusco is a key contact for assistance with preliminary injunctions and damages involving the healthcare, automotive and TMT segments.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Miquel Montañá is the best patent litigator in Spain. You can be sure that your case is in the best hands. The team is super solid and the technical level is amazing.’
‘Miquel Montañá is the best patent litigator in Spain. His track record is amazing and his technical background impressive.’
Kernmandanten
- Novartis
- UCB Pharma
Highlight-Mandate
- Representing Pfizer and Bristol-Myers Squibb in a case where the firm successfully applied for and obtained a preliminary injunction application in relation to the patent that protects apixaban (Eliquis®).
- Representing Astellas in patent revocation proceedings brought by Synthon B.V.